Immunohistochemical analysis of tumour cell xenografts with the CD34/PAS double staining showed that VM was more prevalent in the shControl (4/6) than that in the shZEB1 group (0/6, P < .05, Figure 7D). The gene discussed is CD34; the disease is neoplasm.